P4 MECHANISM OF PROANGIOGENIC ACTIVITY OF MITOCORRECTIN ON ENDOTHELIAL CELLS IN VITRO

Background: Investigations of different effective treatment modalities of infectious and inflammatory complications of stroke remain relevant. Normalization of vascularization, impaired due to hypoxia, is an important component of ischemic disease treating. The aim of our work was to study the mecha...

Full description

Bibliographic Details
Main Authors: Tetiana Nikolaienko, Victoriia Nikulina, Liudmyla Garmanchuk, Oleksander Makarenko
Format: Article
Language:English
Published: Atlantis Press 2018-12-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125930025/view
id doaj-53f39830b8964d9c93fb3494f4ea9fb6
record_format Article
spelling doaj-53f39830b8964d9c93fb3494f4ea9fb62020-11-25T03:49:26ZengAtlantis PressArtery Research 1876-44012018-12-012410.1016/j.artres.2018.10.057P4 MECHANISM OF PROANGIOGENIC ACTIVITY OF MITOCORRECTIN ON ENDOTHELIAL CELLS IN VITROTetiana NikolaienkoVictoriia NikulinaLiudmyla GarmanchukOleksander MakarenkoBackground: Investigations of different effective treatment modalities of infectious and inflammatory complications of stroke remain relevant. Normalization of vascularization, impaired due to hypoxia, is an important component of ischemic disease treating. The aim of our work was to study the mechanism of action of mitocorrectin on endothelial cells in vitro. Methods: Active ingredient of mitocorrectin is a set of oligopeptides and amino acids isolated from cell mitochondria of the liver, brain and the pancreas (10:10:1) of pigs. As an experimental model was used endothelial cell line (PAEC), which was incubated at the standard conditions. Cytotoxic/proliferative effect on cultured cells was determined using cytofluorymetric analysis and MTT-test. Results: Our studies have shown that mitocorrectin increased of endothelial cell by 25% and decreased apoptotic cells almost 2 times compared with the control. Cytofluorymetric analysis revealed an increase 1.8-fold in the population of proliferative cells pool under the influence of mitocorrectin. The most pronounced mitogenic and antiapoptotic effect of mitocorrectin on the endothelial cells was at concentrations of 0.1 – 1/ml. Thus, these doses may be the most therapeutically effective in restoring vascularization in post-stroke period. In addition, long-term cultivation of cells in the 2D-culture when exposed to mitocorrectin, more intensive formation of the capillary-like structures compared with controls, which may indicate vascular morphogenesis. Conclusions: Thus, a study suggests that mitocorrectin shows a positive proangiogenic effect on endothelial cell line and this drug can be quite effective to restore vascularization, which is important in post-stroke period at ischemic complications.https://www.atlantis-press.com/article/125930025/view
collection DOAJ
language English
format Article
sources DOAJ
author Tetiana Nikolaienko
Victoriia Nikulina
Liudmyla Garmanchuk
Oleksander Makarenko
spellingShingle Tetiana Nikolaienko
Victoriia Nikulina
Liudmyla Garmanchuk
Oleksander Makarenko
P4 MECHANISM OF PROANGIOGENIC ACTIVITY OF MITOCORRECTIN ON ENDOTHELIAL CELLS IN VITRO
Artery Research
author_facet Tetiana Nikolaienko
Victoriia Nikulina
Liudmyla Garmanchuk
Oleksander Makarenko
author_sort Tetiana Nikolaienko
title P4 MECHANISM OF PROANGIOGENIC ACTIVITY OF MITOCORRECTIN ON ENDOTHELIAL CELLS IN VITRO
title_short P4 MECHANISM OF PROANGIOGENIC ACTIVITY OF MITOCORRECTIN ON ENDOTHELIAL CELLS IN VITRO
title_full P4 MECHANISM OF PROANGIOGENIC ACTIVITY OF MITOCORRECTIN ON ENDOTHELIAL CELLS IN VITRO
title_fullStr P4 MECHANISM OF PROANGIOGENIC ACTIVITY OF MITOCORRECTIN ON ENDOTHELIAL CELLS IN VITRO
title_full_unstemmed P4 MECHANISM OF PROANGIOGENIC ACTIVITY OF MITOCORRECTIN ON ENDOTHELIAL CELLS IN VITRO
title_sort p4 mechanism of proangiogenic activity of mitocorrectin on endothelial cells in vitro
publisher Atlantis Press
series Artery Research
issn 1876-4401
publishDate 2018-12-01
description Background: Investigations of different effective treatment modalities of infectious and inflammatory complications of stroke remain relevant. Normalization of vascularization, impaired due to hypoxia, is an important component of ischemic disease treating. The aim of our work was to study the mechanism of action of mitocorrectin on endothelial cells in vitro. Methods: Active ingredient of mitocorrectin is a set of oligopeptides and amino acids isolated from cell mitochondria of the liver, brain and the pancreas (10:10:1) of pigs. As an experimental model was used endothelial cell line (PAEC), which was incubated at the standard conditions. Cytotoxic/proliferative effect on cultured cells was determined using cytofluorymetric analysis and MTT-test. Results: Our studies have shown that mitocorrectin increased of endothelial cell by 25% and decreased apoptotic cells almost 2 times compared with the control. Cytofluorymetric analysis revealed an increase 1.8-fold in the population of proliferative cells pool under the influence of mitocorrectin. The most pronounced mitogenic and antiapoptotic effect of mitocorrectin on the endothelial cells was at concentrations of 0.1 – 1/ml. Thus, these doses may be the most therapeutically effective in restoring vascularization in post-stroke period. In addition, long-term cultivation of cells in the 2D-culture when exposed to mitocorrectin, more intensive formation of the capillary-like structures compared with controls, which may indicate vascular morphogenesis. Conclusions: Thus, a study suggests that mitocorrectin shows a positive proangiogenic effect on endothelial cell line and this drug can be quite effective to restore vascularization, which is important in post-stroke period at ischemic complications.
url https://www.atlantis-press.com/article/125930025/view
work_keys_str_mv AT tetiananikolaienko p4mechanismofproangiogenicactivityofmitocorrectinonendothelialcellsinvitro
AT victoriianikulina p4mechanismofproangiogenicactivityofmitocorrectinonendothelialcellsinvitro
AT liudmylagarmanchuk p4mechanismofproangiogenicactivityofmitocorrectinonendothelialcellsinvitro
AT oleksandermakarenko p4mechanismofproangiogenicactivityofmitocorrectinonendothelialcellsinvitro
_version_ 1724495523065364480